Toripalimab Plus Chemo Dubbed New Standard First-Line Therapy for ES-SCLC

Adding toripalimab to chemotherapy improves PFS and OS in newly diagnosed ES-SCLC, a phase 3 trial suggests.

Related Keywords

China ,Changchun ,Jilin ,Ying Liu , ,Jilin Cancer Hospital ,